Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gruber

Showing results (261-270 of 264) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 264 results.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Nature Communications|December 5, 2023
Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptorEdin Muratspahić, Kristine Deibler, Jianming Han, et al.
Natural Product Reports|November 21, 2012
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclaturePaul G Arnison, Mervyn J Bibb, Gabriele Bierbaum, et al.
Pageof 27

Showing results (261-270 of 264) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 264 results.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
ACS Central Science|May 27, 2024
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse AgonistsMiroslav Kosar, Roman C Sarott, David A Sykes, et al.
Nature Communications|December 5, 2023
Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptorEdin Muratspahić, Kristine Deibler, Jianming Han, et al.
Natural Product Reports|November 21, 2012
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclaturePaul G Arnison, Mervyn J Bibb, Gabriele Bierbaum, et al.
Pageof 27